Regeneron AA Multicenter (Dupilumab)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Emma Guttman-Yassky, MD, PhD
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, Irvine
Irvine, California, United States
Natasha A Mesinkovska, MD PhDRecruiting - Icahn School of Medicine at Mount Sinai
New York, New York, United States
Emma Guttman-YasskyRecruiting - Ur Dermatology at College Town
Rochester, New York, United States
Lisa BeckRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Apr 2023
- Primary completion
- 30 Nov 2027
- Completion
- 31 Oct 2028
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 76
- Registry id
- NCT05551793
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.